International Journal of Drug Research and Technology

INVESTIGATING DRUG RESPONSE ASSAY'S POTENTIAL FOR PRECISION THERAPY IN OVARIAN CANCER

Abstract

Whiker Worth*

Different patient reactions to current standard of care anti-cancer medications are one of the biggest obstacles in the treatment of cancer. Different genetic, epigenomic, proteomic, and metabolic abnormalities across people with the same kind of cancer may contribute to these varied responses. Precision medicine is an emerging method in cancer therapies that takes into consideration distinct genomic abnormalities, environmental factors as well as lifestyle of individual patients. Using the patient's unique tumour features, this method enables clinicians and researchers to choose or forecast the treatments that would most likely benefit the patient. Predictive in vitro drug-response assays that measure the sensitivity of patient tumour cells to standard or experimental treatments are one type of precision medicine tool.